Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.
about
Botulinum toxin: State of the art.Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in Spasticity."Appropriate Treatment" and Therapeutic Window in Spasticity Treatment with IncobotulinumtoxinA: From 100 to 1000 Units.Pharmacological differences and clinical implications of various botulinum toxin preparations: a critical appraisal.
P2860
Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Safety and efficacy of incobot ...... b spasticity: The TOWER study.
@en
Safety and efficacy of incobot ...... b spasticity: The TOWER study.
@nl
type
label
Safety and efficacy of incobot ...... b spasticity: The TOWER study.
@en
Safety and efficacy of incobot ...... b spasticity: The TOWER study.
@nl
prefLabel
Safety and efficacy of incobot ...... b spasticity: The TOWER study.
@en
Safety and efficacy of incobot ...... b spasticity: The TOWER study.
@nl
P2093
P2860
P1433
P1476
Safety and efficacy of incobot ...... b spasticity: The TOWER study.
@en
P2093
Astrid Scheschonka
Birgit Flatau-Baqué
David M Simpson
Dirk Dressler
Djamel Bensmail
Edward T J Rochford
Franco Molteni
Joaquim J Ferreira
John McGuire
Jörg Wissel
P2860
P304
P356
10.1212/WNL.0000000000003789
P407
P50
P577
2017-03-10T00:00:00Z